BRIEF-Genmab to receive 25 mln USD milestone payment from Janssen

COPENHAGEN, July 7 Mon Jul 7, 2014 10:22am EDT

Related Topics

COPENHAGEN, July 7 (Reuters) - Genmab A/S : * Reaches $25 million milestone in Daratumumab collaboration with Janssen * Milestone triggered by progress in the phase III study of Daratumumab in combination with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma * Milestone payment is included in Genmab's 2014 financial guidance published on May 1, 2014. Source text for Eikon:

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.